• 1. EWOD-driven droplet microfluidic device integrated with optoelectronic tweezers as an automated platform for cellular isolation and analysis?
  Gaurav J. Shah,Eric P.-Y. Chiou,Ming C. Wu,Chang-Jin “CJ” Kim Lab Chip, 2009,9, 1732-1739
• 2. Dissolved oxygen sensor based on fluorescence quenching of oxygen-sensitive ruthenium complexes immobilized in sol–gel-derived porous silica coatings
  Analyst, 1996,121, 785-788
• 3. Enabling high-throughput single-animal gene-expression studies with molecular and micro-scale technologies
  Jason Wan Lab Chip, 2020,20, 4528-4538
• 4. Fe(ii)-Assisted one-pot synthesis of ultra-small core–shell Au–Pt nanoparticles as superior catalysts towards the HER and ORR?
  Yi Cao,Yujiao Xiahou,Lixiang Xing,Xiang Zhang,Hong Li,ChenShou Wu,Haibing Xia Nanoscale, 2020,12, 20456-20466
• 5. Evolution of calcium phosphate precipitation in hanging drop vapor diffusion by in situRaman microspectroscopy
  Gloria Belén Ramírez-Rodríguez,José Manuel Delgado-López,Jaime Gómez-Morales CrystEngComm, 2013,15, 2206-2212

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Pyrrolopyridines Pyrrolopyridines
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Pyrrolopyridines

Introduction to 5-Chloro-3-iodo-6-methyl-7-azaindole (CAS No. 1000340-16-8)

5-Chloro-3-iodo-6-methyl-7-azaindole, identified by the Chemical Abstracts Service Number (CAS No.) 1000340-16-8, is a heterocyclic compound that has garnered significant attention in the field of pharmaceutical chemistry and medicinal research. This compound belongs to the azaindole class, a structural motif known for its broad biological activity and utility in drug discovery. The presence of multiple substituents, including chlorine, iodine, and methyl groups, makes it a versatile scaffold for further chemical modifications and biological evaluations.

The structural features of 5-Chloro-3-iodo-6-methyl-7-azaindole contribute to its unique chemical properties and reactivity. The chlorine atom at the 5-position and the iodine atom at the 3-position introduce electrophilic centers, making the molecule susceptible to nucleophilic substitution reactions. This characteristic is particularly valuable in synthetic chemistry, where it can be employed to introduce diverse functional groups or to serve as a precursor for more complex molecules. Additionally, the methyl group at the 6-position and the nitrogen atom at the 7-position enhance its solubility and metabolic stability, which are critical factors in drug development.

In recent years, 5-Chloro-3-iodo-6-methyl-7-azaindole has been explored as a key intermediate in the synthesis of various biologically active compounds. Its azaindole core is a privileged scaffold in medicinal chemistry, exhibiting activities against a range of diseases, including cancer, inflammation, and infectious disorders. The halogenated azaindole derivatives have shown particular promise in preclinical studies due to their ability to modulate key biological pathways.

One of the most compelling aspects of 5-Chloro-3-iodo-6-methyl-7-azaindole is its potential as a building block for kinase inhibitors. Kinases are enzymes that play a crucial role in cell signaling pathways, and their dysregulation is often associated with diseases such as cancer. By designing molecules that selectively inhibit specific kinases, researchers can develop targeted therapies with improved efficacy and reduced side effects. The halogen atoms in 5-Chloro-3-iodo-6-methyl-7-azaindole provide handles for further derivatization, allowing chemists to fine-tune the pharmacophore and optimize binding interactions with kinase targets.

Recent studies have highlighted the utility of 5-Chloro-3-iodo-6-methyl-7-azaindole in the development of antiviral agents. The compound’s ability to interfere with viral replication cycles makes it an attractive candidate for treating infectious diseases. For instance, researchers have demonstrated that derivatives of this scaffold can inhibit the replication of certain RNA viruses by targeting essential viral proteins or enzymes. This finding underscores the importance of 5-Chloro-3-iodo-6-methyl-7-azaindole as a versatile starting material for antiviral drug discovery.

The synthesis of 5-Chloro-3-iodo-6-methyl-a zaind ole involves multi-step organic transformations that highlight its synthetic utility. The introduction of chlorine and iodine substituents can be achieved through halogenation reactions, typically using reagents such as N-chlorosuccinimide (NCS) or molecular iodine under controlled conditions. The methyl group can be incorporated via alkylation reactions, while the azaindole core can be constructed from indole derivatives through cyclization reactions. These synthetic strategies demonstrate the flexibility of 5-Chloro -3 -iod o -6 -m ethyl -7 -a zaindo le as a synthetic intermediate.

The pharmacological profile of 5-Chloro -3 -io do -6 -m ethyl -7 -a zaindo le has been extensively studied in vitro and in vivo. Preclinical data suggest that this compound exhibits inhibitory activity against several kinases, including EGFR (epidermal growth factor receptor) and VEGFR (vascular endothelial growth factor receptor). These kinases are implicated in tumor growth and angiogenesis, making them attractive targets for anticancer therapy. Additionally, 5-Chloro -3 -io do -6 -m ethyl -7 -a zaindo le has shown promise in models of inflammation and pain relief, further expanding its therapeutic potential.

The development of novel drug candidates often requires optimization of physicochemical properties such as solubility, bioavailability, and metabolic stability. The structural features of 5-Chloro -3 -io do -6 -m ethyl -7 -a zaindo le, including its halogenated azaindole core and methyl substituent, contribute to these properties in several ways. The halogen atoms increase lipophilicity, which can enhance membrane permeability and improve oral bioavailability. However, they also necessitate careful consideration during drug design to avoid off-target interactions or toxicity.

In conclusion,5-Chlor o -3-i do-o 6-me thyl-o 7-a zai nd o le(CAS No. 1000340 16 8) is a structurally intriguing compound with significant potential in pharmaceutical research. Its unique combination of substituents makes it a valuable intermediate for synthesizing biologically active molecules targeting various diseases. As research continues to uncover new applications for this compound,5-Chlor o --3-i do-o 6-me thyl-o 7-a zai nd o le is likely to remain a cornerstone in drug discovery efforts aimed at developing innovative therapies.

• 1346447-28-6((5-Chloro-3-iodo-1H-pyrrolo2,3-bpyridin-6-yl)methanol)
• 1000340-29-3(3-Iodo-6-methyl-1H-pyrrolo[2,3-b]pyridine)
• 1346447-32-2(5-Chloro-3-iodo-1H-pyrrolo2,3-bpyridine-6-carbaldehyde)
• 900514-08-1(5-Chloro-3-iodo-1H-pyrrolo[2,3-b]pyridine)
• 1000340-18-0(5-Chloro-6-methyl-1H-pyrrolo[2,3-b]pyridine)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)